CN105838724A - Malate dehydrogenase gene RGMDH1 and recombinant expression vector containing same - Google Patents
Malate dehydrogenase gene RGMDH1 and recombinant expression vector containing same Download PDFInfo
- Publication number
- CN105838724A CN105838724A CN201610258934.4A CN201610258934A CN105838724A CN 105838724 A CN105838724 A CN 105838724A CN 201610258934 A CN201610258934 A CN 201610258934A CN 105838724 A CN105838724 A CN 105838724A
- Authority
- CN
- China
- Prior art keywords
- rgmdh1
- ala
- malate dehydrogenase
- val
- gly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010026217 Malate Dehydrogenase Proteins 0.000 title claims abstract description 43
- 238000003259 recombinant expression Methods 0.000 title claims description 9
- 239000013604 expression vector Substances 0.000 title description 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 18
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 10
- 239000002773 nucleotide Substances 0.000 claims abstract description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 102000013460 Malate Dehydrogenase Human genes 0.000 abstract description 28
- 241000588724 Escherichia coli Species 0.000 abstract description 14
- 241000223253 Rhodotorula glutinis Species 0.000 abstract description 10
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 abstract description 6
- 239000013598 vector Substances 0.000 abstract description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract description 4
- 239000001630 malic acid Substances 0.000 abstract description 3
- 235000011090 malic acid Nutrition 0.000 abstract description 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 description 22
- 108090000790 Enzymes Proteins 0.000 description 22
- 230000000694 effects Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 238000012408 PCR amplification Methods 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 108010034529 leucyl-lysine Proteins 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 5
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 3
- 108010010147 glycylglutamine Proteins 0.000 description 3
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000009182 swimming Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- 108010044467 Isoenzymes Proteins 0.000 description 2
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 108010047495 alanylglycine Proteins 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000006356 dehydrogenation reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940049920 malate Drugs 0.000 description 2
- 229940099690 malic acid Drugs 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- BDCLDNALSPBWPQ-UHFFFAOYSA-N 3-oxohexanoic acid Chemical compound CCCC(=O)CC(O)=O BDCLDNALSPBWPQ-UHFFFAOYSA-N 0.000 description 1
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 1
- ZIWWTZWAKYBUOB-CIUDSAMLSA-N Ala-Asp-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O ZIWWTZWAKYBUOB-CIUDSAMLSA-N 0.000 description 1
- CXZFXHGJJPVUJE-CIUDSAMLSA-N Ala-Cys-Leu Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O)N CXZFXHGJJPVUJE-CIUDSAMLSA-N 0.000 description 1
- NBTGEURICRTMGL-WHFBIAKZSA-N Ala-Gly-Ser Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O NBTGEURICRTMGL-WHFBIAKZSA-N 0.000 description 1
- DVJSJDDYCYSMFR-ZKWXMUAHSA-N Ala-Ile-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O DVJSJDDYCYSMFR-ZKWXMUAHSA-N 0.000 description 1
- PMQXMXAASGFUDX-SRVKXCTJSA-N Ala-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCCN PMQXMXAASGFUDX-SRVKXCTJSA-N 0.000 description 1
- IOFVWPYSRSCWHI-JXUBOQSCSA-N Ala-Thr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)N IOFVWPYSRSCWHI-JXUBOQSCSA-N 0.000 description 1
- VYSRNGOMGHOJCK-GUBZILKMSA-N Arg-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N VYSRNGOMGHOJCK-GUBZILKMSA-N 0.000 description 1
- GIVATXIGCXFQQA-FXQIFTODSA-N Arg-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N GIVATXIGCXFQQA-FXQIFTODSA-N 0.000 description 1
- NTAZNGWBXRVEDJ-FXQIFTODSA-N Arg-Asp-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NTAZNGWBXRVEDJ-FXQIFTODSA-N 0.000 description 1
- GRRXPUAICOGISM-RWMBFGLXSA-N Arg-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O GRRXPUAICOGISM-RWMBFGLXSA-N 0.000 description 1
- OPEPUCYIGFEGSW-WDSKDSINSA-N Asn-Gly-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OPEPUCYIGFEGSW-WDSKDSINSA-N 0.000 description 1
- YUUIAUXBNOHFRJ-IHRRRGAJSA-N Asn-Phe-Met Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(O)=O YUUIAUXBNOHFRJ-IHRRRGAJSA-N 0.000 description 1
- WCFCYFDBMNFSPA-ACZMJKKPSA-N Asp-Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O WCFCYFDBMNFSPA-ACZMJKKPSA-N 0.000 description 1
- YDJVIBMKAMQPPP-LAEOZQHASA-N Asp-Glu-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O YDJVIBMKAMQPPP-LAEOZQHASA-N 0.000 description 1
- QCVXMEHGFUMKCO-YUMQZZPRSA-N Asp-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O QCVXMEHGFUMKCO-YUMQZZPRSA-N 0.000 description 1
- LBOVBQONZJRWPV-YUMQZZPRSA-N Asp-Lys-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O LBOVBQONZJRWPV-YUMQZZPRSA-N 0.000 description 1
- ZUNMTUPRQMWMHX-LSJOCFKGSA-N Asp-Val-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O ZUNMTUPRQMWMHX-LSJOCFKGSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000016831 Congenital muscular dystrophy with hyperlaxity Diseases 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108020004460 Fungal RNA Proteins 0.000 description 1
- NNQHEEQNPQYPGL-FXQIFTODSA-N Gln-Ala-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O NNQHEEQNPQYPGL-FXQIFTODSA-N 0.000 description 1
- VUVKKXPCKILIBD-AVGNSLFASA-N Gln-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCC(=O)N)N VUVKKXPCKILIBD-AVGNSLFASA-N 0.000 description 1
- XQDGOJPVMSWZSO-SRVKXCTJSA-N Gln-Pro-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N)N XQDGOJPVMSWZSO-SRVKXCTJSA-N 0.000 description 1
- BBFCMGBMYIAGRS-AUTRQRHGSA-N Gln-Val-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O BBFCMGBMYIAGRS-AUTRQRHGSA-N 0.000 description 1
- LVCHEMOPBORRLB-DCAQKATOSA-N Glu-Gln-Lys Chemical compound NCCCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O LVCHEMOPBORRLB-DCAQKATOSA-N 0.000 description 1
- XTZDZAXYPDISRR-MNXVOIDGSA-N Glu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XTZDZAXYPDISRR-MNXVOIDGSA-N 0.000 description 1
- HMJULNMJWOZNFI-XHNCKOQMSA-N Glu-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N)C(=O)O HMJULNMJWOZNFI-XHNCKOQMSA-N 0.000 description 1
- BKMOHWJHXQLFEX-IRIUXVKKSA-N Glu-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCC(=O)O)N)O BKMOHWJHXQLFEX-IRIUXVKKSA-N 0.000 description 1
- VIPDPMHGICREIS-GVXVVHGQSA-N Glu-Val-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O VIPDPMHGICREIS-GVXVVHGQSA-N 0.000 description 1
- RLFSBAPJTYKSLG-WHFBIAKZSA-N Gly-Ala-Asp Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O RLFSBAPJTYKSLG-WHFBIAKZSA-N 0.000 description 1
- LPCKHUXOGVNZRS-YUMQZZPRSA-N Gly-His-Ser Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O LPCKHUXOGVNZRS-YUMQZZPRSA-N 0.000 description 1
- HMHRTKOWRUPPNU-RCOVLWMOSA-N Gly-Ile-Gly Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O HMHRTKOWRUPPNU-RCOVLWMOSA-N 0.000 description 1
- UWQDKRIZSROAKS-FJXKBIBVSA-N Gly-Met-Thr Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UWQDKRIZSROAKS-FJXKBIBVSA-N 0.000 description 1
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 1
- AFMOTCMSEBITOE-YEPSODPASA-N Gly-Val-Thr Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AFMOTCMSEBITOE-YEPSODPASA-N 0.000 description 1
- NKVZTQVGUNLLQW-JBDRJPRFSA-N Ile-Ala-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)N NKVZTQVGUNLLQW-JBDRJPRFSA-N 0.000 description 1
- QADCTXFNLZBZAB-GHCJXIJMSA-N Ile-Asn-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O)N QADCTXFNLZBZAB-GHCJXIJMSA-N 0.000 description 1
- BALLIXFZYSECCF-QEWYBTABSA-N Ile-Gln-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N BALLIXFZYSECCF-QEWYBTABSA-N 0.000 description 1
- WZDCVAWMBUNDDY-KBIXCLLPSA-N Ile-Glu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O)N WZDCVAWMBUNDDY-KBIXCLLPSA-N 0.000 description 1
- PMMMQRVUMVURGJ-XUXIUFHCSA-N Ile-Leu-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O PMMMQRVUMVURGJ-XUXIUFHCSA-N 0.000 description 1
- GLYJPWIRLBAIJH-UHFFFAOYSA-N Ile-Lys-Pro Natural products CCC(C)C(N)C(=O)NC(CCCCN)C(=O)N1CCCC1C(O)=O GLYJPWIRLBAIJH-UHFFFAOYSA-N 0.000 description 1
- MLSUZXHSNRBDCI-CYDGBPFRSA-N Ile-Pro-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)O)N MLSUZXHSNRBDCI-CYDGBPFRSA-N 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- PDQDCFBVYXEFSD-SRVKXCTJSA-N Leu-Leu-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PDQDCFBVYXEFSD-SRVKXCTJSA-N 0.000 description 1
- RXGLHDWAZQECBI-SRVKXCTJSA-N Leu-Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O RXGLHDWAZQECBI-SRVKXCTJSA-N 0.000 description 1
- BIZNDKMFQHDOIE-KKUMJFAQSA-N Leu-Phe-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=CC=C1 BIZNDKMFQHDOIE-KKUMJFAQSA-N 0.000 description 1
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 1
- RIHIGSWBLHSGLV-CQDKDKBSSA-N Leu-Tyr-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O RIHIGSWBLHSGLV-CQDKDKBSSA-N 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- FZIJIFCXUCZHOL-CIUDSAMLSA-N Lys-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN FZIJIFCXUCZHOL-CIUDSAMLSA-N 0.000 description 1
- NTSPQIONFJUMJV-AVGNSLFASA-N Lys-Arg-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O NTSPQIONFJUMJV-AVGNSLFASA-N 0.000 description 1
- OVIVOCSURJYCTM-GUBZILKMSA-N Lys-Asp-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O OVIVOCSURJYCTM-GUBZILKMSA-N 0.000 description 1
- AAORVPFVUIHEAB-YUMQZZPRSA-N Lys-Asp-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O AAORVPFVUIHEAB-YUMQZZPRSA-N 0.000 description 1
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 1
- ITWQLSZTLBKWJM-YUMQZZPRSA-N Lys-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCCN ITWQLSZTLBKWJM-YUMQZZPRSA-N 0.000 description 1
- RIJCHEVHFWMDKD-SRVKXCTJSA-N Lys-Lys-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O RIJCHEVHFWMDKD-SRVKXCTJSA-N 0.000 description 1
- OBZHNHBAAVEWKI-DCAQKATOSA-N Lys-Pro-Asn Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O OBZHNHBAAVEWKI-DCAQKATOSA-N 0.000 description 1
- PLOUVAYOMTYJRG-JXUBOQSCSA-N Lys-Thr-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O PLOUVAYOMTYJRG-JXUBOQSCSA-N 0.000 description 1
- 101150058595 MDH gene Proteins 0.000 description 1
- 101100290485 Medicago sativa CMDH gene Proteins 0.000 description 1
- MYAPQOBHGWJZOM-UWVGGRQHSA-N Met-Gly-Leu Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C MYAPQOBHGWJZOM-UWVGGRQHSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-M NAD(1-) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-M 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- MQVFHOPCKNTHGT-MELADBBJSA-N Phe-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O MQVFHOPCKNTHGT-MELADBBJSA-N 0.000 description 1
- HNFUGJUZJRYUHN-JSGCOSHPSA-N Phe-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 HNFUGJUZJRYUHN-JSGCOSHPSA-N 0.000 description 1
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 1
- IFMDQWDAJUMMJC-DCAQKATOSA-N Pro-Ala-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O IFMDQWDAJUMMJC-DCAQKATOSA-N 0.000 description 1
- KPDRZQUWJKTMBP-DCAQKATOSA-N Pro-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 KPDRZQUWJKTMBP-DCAQKATOSA-N 0.000 description 1
- FUOGXAQMNJMBFG-WPRPVWTQSA-N Pro-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 FUOGXAQMNJMBFG-WPRPVWTQSA-N 0.000 description 1
- MMGJPDWSIOAGTH-ACZMJKKPSA-N Ser-Ala-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O MMGJPDWSIOAGTH-ACZMJKKPSA-N 0.000 description 1
- BRKHVZNDAOMAHX-BIIVOSGPSA-N Ser-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N BRKHVZNDAOMAHX-BIIVOSGPSA-N 0.000 description 1
- DKKGAAJTDKHWOD-BIIVOSGPSA-N Ser-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N)C(=O)O DKKGAAJTDKHWOD-BIIVOSGPSA-N 0.000 description 1
- YRBGKVIWMNEVCZ-WDSKDSINSA-N Ser-Glu-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O YRBGKVIWMNEVCZ-WDSKDSINSA-N 0.000 description 1
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 1
- VZQRNAYURWAEFE-KKUMJFAQSA-N Ser-Leu-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 VZQRNAYURWAEFE-KKUMJFAQSA-N 0.000 description 1
- UGGWCAFQPKANMW-FXQIFTODSA-N Ser-Met-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O UGGWCAFQPKANMW-FXQIFTODSA-N 0.000 description 1
- 206010067130 Spastic diplegia Diseases 0.000 description 1
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 1
- BBPCSGKKPJUYRB-UVOCVTCTSA-N Thr-Thr-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O BBPCSGKKPJUYRB-UVOCVTCTSA-N 0.000 description 1
- KVEWWQRTAVMOFT-KJEVXHAQSA-N Thr-Tyr-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O KVEWWQRTAVMOFT-KJEVXHAQSA-N 0.000 description 1
- AKHDFZHUPGVFEJ-YEPSODPASA-N Thr-Val-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AKHDFZHUPGVFEJ-YEPSODPASA-N 0.000 description 1
- QNXZCKMXHPULME-ZNSHCXBVSA-N Thr-Val-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O QNXZCKMXHPULME-ZNSHCXBVSA-N 0.000 description 1
- OETOOJXFNSEYHQ-WFBYXXMGSA-N Trp-Ala-Asp Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O)=CNC2=C1 OETOOJXFNSEYHQ-WFBYXXMGSA-N 0.000 description 1
- JLFKWDAZBRYCGX-ZKWXMUAHSA-N Val-Asn-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N JLFKWDAZBRYCGX-ZKWXMUAHSA-N 0.000 description 1
- JZWZACGUZVCQPS-RNJOBUHISA-N Val-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N JZWZACGUZVCQPS-RNJOBUHISA-N 0.000 description 1
- UMPVMAYCLYMYGA-ONGXEEELSA-N Val-Leu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O UMPVMAYCLYMYGA-ONGXEEELSA-N 0.000 description 1
- RWOGENDAOGMHLX-DCAQKATOSA-N Val-Lys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)N RWOGENDAOGMHLX-DCAQKATOSA-N 0.000 description 1
- GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 1
- PDDJTOSAVNRJRH-UNQGMJICSA-N Val-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](C(C)C)N)O PDDJTOSAVNRJRH-UNQGMJICSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 1
- 108010045350 alanyl-tyrosyl-alanine Proteins 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 1
- 108010028188 glycyl-histidyl-serine Proteins 0.000 description 1
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 108010027338 isoleucylcysteine Proteins 0.000 description 1
- 108010083708 leucyl-aspartyl-valine Proteins 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 230000005868 ontogenesis Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-M oxaloacetate ion Chemical compound OC(=O)C(=O)CC([O-])=O KHPXUQMNIQBQEV-UHFFFAOYSA-M 0.000 description 1
- -1 oxalyl Acetate Chemical compound 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000019525 primary metabolic process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108010004914 prolylarginine Proteins 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000004441 taeniasis Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01037—Malate dehydrogenase (1.1.1.37)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses a nucleotide sequence which is separated from rhodotorula glutinis YM25079 and is used for coding malate dehydrogenase. The nucleotide sequence is shown in SEQ ID NO:1. An amino acid sequence coded by a gene is shown in SEQ ID NO:2. By constructing a recombinant vector and expressing the recombinant vector in escherichia coli, an expression product has the function of malate dehydrogenase and can catalytically convert malic acid to oxaloacetic acid.
Description
Technical field
The present invention relates to a kind of malate dehydrogenase gene RGMDH1 and recombinant expression carrier thereof, be specifically related to viscous red ferment
The cDNA of female (Rhodotorula glutinis) YM25079 total serum IgE reverse transcription is template, and amplification obtains encoding malate dehydrogenation
The gene of enzyme (MDH), is cloned into abduction delivering after coli expression carrier, and affinity chromatography obtains pure enzyme after purification,
And this enzyme has been carried out the correlational study of enzyme activity determination and zymologic property, belong to genetic engineering and enzyme engineering field.
Background technology
Malic dehydrogenase (MDH) is distributed widely in organism, is the enzyme that a kind of activity is the strongest, and it is catalyzed oxalyl
Acetate and the mutual conversion reaction of malate are relevant to the oxidoreduction of dinucleotide coenzyme.Oxaloacetate is in many
Metabolic pathway all plays an important role, including tricarboxylic acid cycle, glyoxylate bypass, Amino acid synthesis, gluconeogenesis etc., and maintains
Redox equilibrium, moreover it is possible to promote kytoplasm and the exchange of subcellular organelle metabolite.According to the function difference of organism, histological difference,
Its expression kind of the difference of intracellular targeting is different, and MDH has multiple isozyme form.CyMD (cMDH) is deposited
In being cell cytoplasm, it is responsible for and NADH is proceeded to mitochondrial important task, and also regulation and control tricarboxylic acid cycle is had effect, simultaneously
CMDH or an ingredient of nucleic acid path (NACh) complex.
Malic dehydrogenase (MDH) is widely distributed in animal tissue, microorganism and plant.It is that a kind of activity is the strongest
Enzyme, according to Subcellular Localization, malic dehydrogenase can be divided into 5 types, be present in glyoxalic acid body, mitochondrion, peroxidase precursor,
In chloroplast, cytoplasm and trypanosomicide glycerol body.MDH is polymer enzyme, the dimer being made up of same or similar subunit or
The tetramer, the molecular weight of subunit is that 30-35kDa, MDH also cause increasing concern such as to utilize genetic engineering in terms of medical science
Vaccine prevention human body taeniasis has been the research direction received much concern, by the biology of Bovine luteinizing hormone MDH gene
Bioinformatics analysis, it is predicted that endochylema type MDH is a potential diagnostic antigen, this grinds at diagnosis, medicine and vaccine for band cestode
Application prospect in studying carefully provides important clue, for multienzyme analysis and the early diagnosis of disease in clinical diagnosis, such as
For diagnosing DIC(disseminated inravascular coagulation), myocardial infarction, acute, chronic hepatitis etc..At field of food, malic dehydrogenase is used
In the mensuration of organic acid content, the mensuration of the materials such as acid as bright in L-Herba Marsileae Quadrifoliae, acetic acid, citric acid, application prospect is extensive.Utilize at the bottom of MDH
Thing specificity, also can use it for splitting D, L MALIC ACID enzyme.In a word, MDHs is as the key of organism central metabolism approach
Enzyme, to it, oneself has carried out relatively broad research both at home and abroad, and MDHs isozyme is just being applied to biological classification, species differentiation, heredity
The researchs such as variation, species hybridization and ontogeny.Therefore the physio-biochemical characteristics of MDHs, structure and function, catalysis are understood in depth
Mechanism, for expression, purification and the Immunogenicity of enzyme recombiant protein, inquires into the metabolism and of MDHs in organism
The molecule mechanism of causing a disease of a little diseases has great significance.The applied research of MDH also will promote MDHs transgenic plant simultaneously
And the further development of chiral drug.
Summary of the invention
It is an object of the invention to provide what one separated from rhodotorula glutinis (Rhodotorula glutinis) YM25079
Malate dehydrogenase gene RGMDH1, this gene nucleotide series as shown in SEQ ID NO:1 or the fragment of this nucleotide sequence,
Or the nucleotide sequence complementary with SEQ ID NO:1, this gene order a length of 978bp(base), the aminoacid of this gene code
Sequence polypeptide as shown in SEQ ID NO:2 or its fragment.
Another object of the present invention is to provide the recombinant expressed of a kind of malate dehydrogenase gene RGMDH1 containing and having separated
Carrier, by gene shown in SEQ ID NO:1 directly with different expression vectors (plasmid, virus or carrier) connection constructed by
Recombinant vector.
Another object of the present invention be to provide a kind of recombinant expression carrier containing this malate dehydrogenase gene RGMDH1 or
Host cell E. coli (Escherichia coli) the bacterial strain BL21 of above-mentioned recombinant expression carrier.
Can be with this with nucleotide sequence of the present invention or the recombinant vector transformed host cell containing nucleotide sequence
Method known to the technical staff in field is carried out.When host is prokaryote such as escherichia coli, use CaCl2, the side such as electroporation
Method is carried out.When host is eukaryote, can be selected for the methods such as DNA infection protocol, microinjection, electroporation, liposome packaging.
The nucleotide sequence that the present invention provides is a kind of malate dehydrogenase gene efficient, specific, can by its with
Carrier converts to microbial cell body production malic dehydrogenase after connecting, have product specificities high, with short production cycle, raw
Produce and do not affected and utilize different strains and culture medium to be suitable for exploitation commercialization malic dehydrogenase by place, weather, season
Etc. advantage;Present invention application technique for gene engineering builds specificity and produces the transgenic escherichia coli production Herba Marsileae Quadrifoliae of malic dehydrogenase
Fruit acid dehydrogenase, has simple to operate, low cost, feasibility advantages of higher, produces for malate dehydrogenase gene through engineering approaches and establishes
Fixed basis.
Accompanying drawing explanation
Fig. 1 is the escherichia coli utilizing the rhodotorula glutinis YM25079 malate dehydrogenase gene RGMDH1 of the present invention to build
Recombinant expression plasmid pET32aRGMDH1 plasmid map;
Fig. 2 is malate dehydrogenase gene RGMDH1 abduction delivering the SDS-PAGE analysis chart after purification of the present invention, wherein:
1 is protein electrophoresis Marker;2 for converted pET32a (+) and through IPTG induction e. coli bl21 total protein;3 for converting
PET32aRGMDH1 through the e. coli bl21 total protein of IPTG induction;4 is the destination protein band of purification.
Detailed description of the invention
With embodiment, the present invention is described in further detail below in conjunction with the accompanying drawings, but scope is not limited to
Described content, the reagent used in embodiment and method, if no special instructions, all use conventional reagent and use conventional method.
Embodiment 1: the clone of rhodotorula glutinis malate dehydrogenase gene RGMDH1
Use OMEGA test kit E.Z.N.A Fungal RNA Kit from rhodotorula glutinis (Rhodotorula glutinis)
YM25079 extracts total serum IgE, with Reverse Transcription box Thermo Scientific Maxima H Minus First
Strand cDNA Synthesis Kit synthesizes cDNA, and taking 1 μ l is that template carries out polymerase chain reaction.Design primer (primer
1 and primer 2) carry out PCR amplification, reaction the primer, component and amplification condition are as follows:
Primer P1:RGMDHF1:5`-ATGGGCCTCAAGACTGCTGTTCTC-3` (SEQ ID NO:3)
Primer P2:RGMDHR1:5`-TTACTGCTTCATGAAGTTCTGAC-3` (SEQ ID NO:4)
PCR amplification system (50 μ L) composition is as follows:
5×Trans PFU Buffer 10μL
DNTP(2.5 μm ol/L) 5 μ L
cDNA 1μL
RGMDHF1(10 μm ol/L) 2 μ L
RGMDHR1(10 μm ol/L) 2 μ L
Fast Pfu DNA polymerase(5U/ μ L) 2 μ L
Aseptic ddH2O complements to 50 μ L;
Amplification condition: 94 DEG C of degeneration 4min, then carry out 30 circulations with 94 DEG C of 45s, 56 DEG C of 45s, 72 DEG C of 90s, last 72 DEG C
10min, takes product 1 μ L, then in the agarose gel that concentration is 1%, carries out electrophoretic analysis after having reacted.Through gel imaging
After system imaging confirms that clip size is correct, purify with hundred Tyke Bioisystech Co., Ltd many kinetic energy DNA and reclaim test kit and return
Receive purpose fragment, then the genes of interest that PCR amplification obtains is connected on pMD18-T, connect product and convert bacillus coli DH 5
α, screens with the LB solid plate containing ampicillin (Amp+), and the transformant on picking flat board carries out bacterium colony PCR sieve
Select positive colony, be then sent for Shanghai raw work order-checking.Sequencing result result shows, it is thus achieved that the sequence of one section of 978bp length, named
RGMDH1, sequence composition nucleotide sequence as shown in SEQ ID NO:1.
Embodiment 2: the structure of recombinant expression plasmid pET32aRGMDH1
Using the cDNA in embodiment 1 is that template carries out PCR amplification, reaction the primer combination, reactive component and amplification condition
As follows:
Primer P3:RGMDHF2:5`-TACGGATCCATGGGCCTCAAGACTGCT-3` (SEQ ID NO:5)
Primer P4:RGMDHR2:5`-CGTCTCGAGCTGCTTCATGAAGTTCTG-3` (SEQ ID NO:6)
PCR amplification system (50 L) composition is as follows:
5×Fast Pfu Buffer 10μL
DNTP(2.5 mol/L) 5 μ L
cDNA 1μL
RGMDHF2(10 mol/L) 1 μ L
RGMDHR2(10 mol/L) 1 μ L
Fast Pfu DNA polymerase(5U/ L) 1 μ L
Aseptic ddH2O complements to 50 μ L;
Amplification condition: 94 DEG C of degeneration 4min, then carry out 30 circulations with 94 DEG C of 45s, 59 DEG C of 45s, 72 DEG C of 2min, last 72
℃ 10min;The PCR primer and the plasmid pET-32a that take purification use BamH I and Xho I enzyme action overnight respectively, 50 μ l PCR primer
Reaction system: PCR primer 25 μ L, 10 × Tango Buffer 10 μ l, BamH I 2 μ l and Xho I 1.5 μ L, double with sterilizing
Steaming water polishing, 37 DEG C of enzyme action are overnight.50 μ l plasmid pET-32a reaction systems: plasmid pET-32a 15 μ l, 10 × Tango
Buffer 10 μ l, BamH I 2 μ l and Xho I1.5 μ L, with the distilled water polishing of sterilizing, 37 DEG C of enzyme action are overnight.Electrophoresis inspection enzyme
Cut product, and reclaim test kit with gel and digestion products is purified and reclaims.Linked system (10 μ L): the PCR of purification produces
Thing and expression vector pET-32a press 7:1 sample-adding, T4DNA ligase 0.5 μ L, T4 Buffer 1 μ L, and 16 DEG C connect overnight.Take
Connect product to proceed in bacillus coli DH 5.After 37 DEG C of shaken cultivation 1.5h, the culture fluid coating LB culture medium containing ammonia benzyl is put down
Plate, cultivates 12h in 37 DEG C of incubators, the transformant on picking flat board carries out bacterium colony PCR, screening positive clone, builds and obtains weight
The group named pET32aRGMDH1 of expression plasmid, this plasmid map is as shown in Figure 1.
Embodiment 3: malate dehydrogenase gene RGMDH1 abduction delivering in e. coli bl21
1, the abduction delivering of malate dehydrogenase pheron RGMDH1 and purification
In order to verify the activity of this gene coded protein, 1 μ g recombiant plasmid pET32aRGMDH1 is added 50 μ L escherichia coli
In BL21 competent cell, by after whole system ice bath 30min in 42 DEG C of thermal shock 90s, again ice bath 2min, then will even
Junctor system draws and adds to 950 μ L LB fluid mediums, 37 DEG C, 100rpm oscillation incubation 1h.Hatch after end in
5000rpm is centrifuged 10 min, coats the LB containing ampicillin (Amp+) solid after leaving about 80 μ L supernatant suspension precipitations
Body flat board, is inverted for 37 DEG C and cultivates 10h.
Picking positive transformant in 100 mL LB (containing 100 μ g/mL ammonia benzyl mycins) culture medium, 37 DEG C of shaken cultivation mistakes
At night, the bacterium solution of enrichment being inoculated in 1L LB fluid medium in 1% ratio, in 37 DEG C, 160rpm cultivates to OD600 value about
0.8.Taking 5ml bacterium solution as blank, remaining adds IPTG to final concentration of 1mmol/L, lures in 15 DEG C of constant-temperature table 80rpm
Leading cultivation 8 hours, 12000 rpm are centrifuged 15min and collect thalline.SDS-PAGE analyzes display, and it is big that pET32aRGMDH1 converts
Enterobacteria gives expression to the albumen (see Fig. 2 swimming lane 3) that a molecular weight is about 50kD, but at empty carrier pET32a(+) convert
Escherichia coli do not have (see Fig. 2 swimming lane 2).
It is suspended in this thalline further and (makes the OD of bacteria suspension in right amount600≈ 20) 30 mM imidazole buffer in, on ice
Sonicated cells, 4 DEG C, 14000 rpm be centrifuged 15 min.The supernatant miniature membrane filtration of 0.2 μm after being centrifuged, filter
Liquid is splined on the His Trap HP post (1 ml, GE Healthcare) balanced with 30mM imidazole buffer, uses 200mM miaow
Azoles buffer carries out eluting, and eluent centrifuge tube is collected in order, elution samples SDS-PAGE electrophoresis detection, it is thus achieved that is pure
Protein band (see Fig. 2 swimming lane 4).
2, the enzyme activity determination of malic dehydrogenase RGMDH1
Malic dehydrogenase is the key enzyme of regulating apple acid metabolic, can be catalyzed malic acid and carry out dehydrogenation oxidation, along with product
SHENGCAO ethyl acetoacetic acid and NADH.Owing to the enzyme work of MDH concentration change with product NADH within certain response time is line
Sexual relationship, so the activity of MDH can be measured by the concentration change of detection NADH.With malic acid and NAD(+) it is that substrate adds
Malic dehydrogenase reacts, and measures enzyme with ultraviolet spectrophotometer and live at 340nm.MDH enzyme live calculating:
Unit definition: enzyme activity unit refers to enzyme amount when 25 DEG C needed for generation 1 molNADH per minute.
Malic dehydrogenase enzyme computing formula alive:
E=[(Δe/Δt) ×Vt×df]/(ε×D×Vs×C)
=[(0.315-0.236)×1.9×95]/(6.42×1×0.02×0.3482)
=318.93U/mg
Vt-----reaction solution cumulative volume (ml)
The absorbance of the NADH that ε-----measures at 340nm is 6.42
D-----optical path length (1cm) (cuvette diameter)
Vs-----enzyme liquid amasss (ml)
C-----protein concentration (mg/ml)
The change of absorbance at 340nm in Δ e/ Δ t----1min
Df----dilution gfactor
Result shows, the enzyme work of purified malic dehydrogenase RGMDH1 is 318.93 U/mg, shows that gene recombined vector exists
In e. coli bl21, abduction delivering malic dehydrogenase RGMDH1 out has the activity of malic dehydrogenase.
Sequence table
<110>Kunming University of Science and Technology
<120>a kind of malate dehydrogenase gene RGMDH1 and recombinant expression carrier thereof
<160> 6
<170> PatentIn version 3.5
<210> 1
<211> 978
<212> DNA
<213>rhodotorula glutinis
<400> 1
atgggcctca agactgctgt tctcggcgct gctggtggca tcggccagcc cctcgccctt 60
ctcctcaagc agaacccggc catcaccgag ctcgccctgt tcgatgtcgt ccccgtcgtc 120
aagggcgtcg ccgccgacat cggccacgtc gactcgcccg ccgtcacgac gggctacgtc 180
aaggacgagg acggccttaa gggcgccctc accggcgccg acctcgtcgt catccccgcc 240
ggcgtcccgc gtaagcccgg catgacgcgc gacgacctgt tcaacatcaa cgccggcatc 300
gtgcgcgacc tcgcccaggg catcgccgac ttctgcccaa aggccttcgt cctcatcatc 360
tcgaacccgg tcaactcgac cgtgcccatc gccgccgagg tcctcaaggc cgccggcgtc 420
tttgacccca agcgcgtgtt cggcgtcacc accctcgacg tcgtccgtgc gtcgaccatg 480
tcggcgcagg ccatcggcaa gcccaactcg gcgcccgagt acacgatccc ggtcgtcggc 540
ggccactctg gcgtgacgat cctcccgctc ctgtcgcagg cccagccggc gctccccaag 600
tcgctgttcg acgacgaggc caagctcaag gagctcgtca agcgcatcca gtttggcggt 660
gacgaggtcg tcaaggccaa ggacggcgct gggtcggcca ccctctcgat ggcgtacgcc 720
ggtgccgact gggccgactc gctcctccgc gccatgaacg gcgagcaggt cgagatctgc 780
acctacgtcg agtcgcccct ctacgccgac aagggcgtca cgttcttttc gtcgcccgtg 840
acgatctcct cggagggcac ggtcggcgag atcaagcccg tcggccagct gcacgagtcg 900
gagcagaagc tcctcgacgc gtgcctcccg gacctcaaga aaaacatcga ggccggtcag 960
aacttcatga agcagtaa 978
<210> 2
<211> 325
<212> PRT
<213>rhodotorula glutinis
<400> 2
MET Gly Leu Lys Thr Ala Val Leu Gly Ala Ala Gly Gly Ile Gly Gln Pro Leu Ala Leu
5 15
Leu Leu Lys Gln Asn Pro Ala Ile Thr Glu Leu Ala Leu Phe Asp Val Val Pro Val Val
25 35
Lys Gly Val Ala Ala Asp Ile Gly His Val Asp Ser Pro Ala Val Thr Thr Gly Tyr Val
45 55
Lys Asp Glu Asp Gly Leu Lys Gly Ala Leu Thr Gly Ala Asp Leu Val Val Ile Pro Ala
65 75
Gly Val Pro Arg Lys Pro Gly MET Thr Arg Asp Asp Leu Phe Asn Ile Asn Ala Gly Ile
85 95
Val Arg Asp Leu Ala Gln Gly Ile Ala Asp Phe Cys Pro Lys Ala Phe Val Leu Ile Ile
105 115
Ser Asn Pro Val Asn Ser Thr Val Pro Ile Ala Ala Glu Val Leu Lys Ala Ala Gly Val
125 135
Phe Asp Pro Lys Arg Val Phe Gly Val Thr Thr Leu Asp Val Val Arg Ala Ser Thr MET
145 155
Ser Ala Gln Ala Ile Gly Lys Pro Asn Ser Ala Pro Glu Tyr Thr Ile Pro Val Val Gly
165 175
Gly His Ser Gly Val Thr Ile Leu Pro Leu Leu Ser Gln Ala Gln Pro Ala Leu Pro Lys
185 195
Ser Leu Phe Asp Asp Glu Ala Lys Leu Lys Glu Leu Val Lys Arg Ile Gln Phe Gly Gly
205 215
Asp Glu Val Val Lys Ala Lys Asp Gly Ala Gly Ser Ala Thr Leu Ser MET Ala Tyr Ala
225 235
Gly Ala Asp Trp Ala Asp Ser Leu Leu Arg Ala MET Asn Gly Glu Gln Val Glu Ile Cys
245 255
Thr Tyr Val Glu Ser Pro Leu Tyr Ala Asp Lys Gly Val Thr Phe Phe Ser Ser Pro Val
265 275
Thr Ile Ser Ser Glu Gly Thr Val Gly Glu Ile Lys Pro Val Gly Gln Leu His Glu Ser
285 295
Glu Gln Lys Leu Leu Asp Ala Cys Leu Pro Asp Leu Lys Lys Asn Ile Glu Ala Gly Gln
305 315
Asn Phe MET Lys Gln ***
325
<210> 3
<211> 24
<212> DNA
<213>artificial sequence
<400> 3
atgggcctca agactgctgt tctc 24
<210> 4
<211> 23
<212> DNA
<213>artificial sequence
<400> 4
ttactgcttc atgaagttct gac 23
<210> 5
<211> 27
<212> DNA
<213>artificial sequence
<400> 5
tacggatcca tgggcctcaa gactgct 27
<210> 6
<211> 27
<212> DNA
<213>artificial sequence
<400> 6
cgtctcgagc tgcttcatga agttctg 27
Claims (2)
1. a malate dehydrogenase gene RGMDH1, its nucleotide sequence as shown in SEQ ID NO:1, the ammonia of this gene code
Base acid sequence is as shown in SEQ ID NO:2.
2. the recombinant expression carrier containing malate dehydrogenase gene RGMDH1 described in claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610258934.4A CN105838724B (en) | 2016-04-25 | 2016-04-25 | A kind of malate dehydrogenase gene RGMDH1 and its recombinant expression carrier |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610258934.4A CN105838724B (en) | 2016-04-25 | 2016-04-25 | A kind of malate dehydrogenase gene RGMDH1 and its recombinant expression carrier |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105838724A true CN105838724A (en) | 2016-08-10 |
CN105838724B CN105838724B (en) | 2019-09-27 |
Family
ID=56589098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610258934.4A Active CN105838724B (en) | 2016-04-25 | 2016-04-25 | A kind of malate dehydrogenase gene RGMDH1 and its recombinant expression carrier |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105838724B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108753802A (en) * | 2018-05-22 | 2018-11-06 | 昆明理工大学 | One malate dehydrogenase gene CIMDH1 and its recombinant expression carrier |
CN109337879A (en) * | 2018-12-21 | 2019-02-15 | 厦门大学 | A kind of malic dehydrogenase PbMDH and its coded sequence and application |
CN109777815A (en) * | 2019-03-28 | 2019-05-21 | 昆明理工大学 | HMG-CoA synthase gene RKHMGCS and its application |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104673810A (en) * | 2015-01-23 | 2015-06-03 | 昆明理工大学 | Malic dehydrogenase gene MIMDH1 and recombinant expression vector thereof |
CN105296509A (en) * | 2015-11-16 | 2016-02-03 | 昆明理工大学 | Malate dehydrogenase gene RKMDH2 and recombinant expression vector thereof |
CN105400711A (en) * | 2015-12-30 | 2016-03-16 | 江南大学 | Establishment and application of brewing yeast engineering bacterium strain for producing L-malic acid |
-
2016
- 2016-04-25 CN CN201610258934.4A patent/CN105838724B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104673810A (en) * | 2015-01-23 | 2015-06-03 | 昆明理工大学 | Malic dehydrogenase gene MIMDH1 and recombinant expression vector thereof |
CN105296509A (en) * | 2015-11-16 | 2016-02-03 | 昆明理工大学 | Malate dehydrogenase gene RKMDH2 and recombinant expression vector thereof |
CN105400711A (en) * | 2015-12-30 | 2016-03-16 | 江南大学 | Establishment and application of brewing yeast engineering bacterium strain for producing L-malic acid |
Non-Patent Citations (2)
Title |
---|
EIKO TSUCHIYA等: "Physiological changes of rhodotorula glutinis induced by an acid protease inhibitor(S-PI)", 《AGRICULTURAL AND BIOLOGICAL CHEMISTRY》 * |
LLLIAS RM等: "L-Mandelate dehydrogenase from Rhodotorula graminis:cloning,sequencing and kinetic characterization of the recombinant enzyme and its independently expressed flavin domain.", 《BIOCHEM J》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108753802A (en) * | 2018-05-22 | 2018-11-06 | 昆明理工大学 | One malate dehydrogenase gene CIMDH1 and its recombinant expression carrier |
CN108753802B (en) * | 2018-05-22 | 2021-07-16 | 昆明理工大学 | Malic dehydrogenase gene CIMDH1 and recombinant expression vector thereof |
CN109337879A (en) * | 2018-12-21 | 2019-02-15 | 厦门大学 | A kind of malic dehydrogenase PbMDH and its coded sequence and application |
CN109777815A (en) * | 2019-03-28 | 2019-05-21 | 昆明理工大学 | HMG-CoA synthase gene RKHMGCS and its application |
Also Published As
Publication number | Publication date |
---|---|
CN105838724B (en) | 2019-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104673810B (en) | A kind of malate dehydrogenase gene MIMDH1 and its recombinant expression carrier | |
CN104673809B (en) | A kind of malate dehydrogenase gene and its recombinant expression carrier | |
CN109055327A (en) | Aldehyde Ketoreductase mutant and its application | |
CN105296509B (en) | A kind of malate dehydrogenase gene RKMDH2 and its recombinant expression carrier | |
US20190136219A1 (en) | Genetically Engineered Arginine Deiminase Modified by Site-Directed Mutagenesis | |
CN105838724B (en) | A kind of malate dehydrogenase gene RGMDH1 and its recombinant expression carrier | |
CN109554414A (en) | Application of needle mushroom gene Fvegt1, Fvegt2 and the Fvegt3 in synthesis erythrothioneine | |
CN107794251A (en) | A kind of deep-sea development of new type alkali-resistant fibre esterase and application | |
CN107177607A (en) | Bacillus subtilis BS04 urate oxidase gene and application thereof | |
JP7387194B2 (en) | Biosynthesis of vanillin from isoeugenol | |
CN103114110B (en) | Method for synthesizing bilirubin by utilizing immobilized enzyme | |
CN109929822A (en) | A kind of Aspergillus oryzae lipase mutant and its application | |
CN109913380A (en) | Produce (-)-α-bisabolol recombination Yarrowia lipolytica and its construction method and application | |
CN105886517B (en) | A kind of malate dehydrogenase gene RKMDH1 and its recombinant expression carrier | |
CN105349557B (en) | A kind of malic enzyme gene RKME2 and its recombinant expression carrier | |
CN107488639A (en) | Toluene monooxygenase and its application in the synthesis of chiral sulfoxide living things catalysis | |
CN108753802B (en) | Malic dehydrogenase gene CIMDH1 and recombinant expression vector thereof | |
CN106544328A (en) | A kind of sulfoxide reductase and its application and preparation method | |
CN109337879B (en) | Malate dehydrogenase PbMDH and coding sequence and application thereof | |
CN106636019B (en) | High-efficiency catalytic synthesis of (S) -phenyl glycol by using (S) -carbonyl reductase oligomer mediated by Sortase A | |
CN102898512A (en) | Recombinant plectasin as well as preparation method and application of recombinant plectasin | |
CN101457217B (en) | Thermophilic lipase with alpha-phenyl ethyl alcohol disassemble activity, coding gene and use thereof | |
CN104673808B (en) | A kind of malic enzyme gene and its recombinant expression carrier | |
CN109609523A (en) | Two kinds of genes for being catalyzed peach UDP- rhamnose biosynthesis and coding albumen and application | |
CN109161555A (en) | A kind of marine low temperature malate dehydrogenase gene and its recombinant expression carrier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |